Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial.
Zhenquan WuJinfeng ZhaoWaiching LamMingmin YangLu ChenXuelin HuangMeirong WeiHui YangFan LvFuyan ZhangJian ZengGuo-Ming ZhangPublished in: The British journal of ophthalmology (2021)
Both IVC and IVR are effective therapies for the treatment of ROP. Conbercept is a new option for treating ROP.